The Role of Biomarkers in Clinical Trials
Biomarkers ù measurable biological indicators ù are increasingly used as primary or secondary endpoints in clinical trials. They can indicate disease progression, response to therapy, or patient stratification.
Types of Biomarker Testing at CIRI
- Immunogenicity and Vaccine Serology testing
- Flow Cytometry for immunophenotyping
- Advanced Immunology panels
- Molecular Biology assays (PCR, NGS support)
- Pharmacokinetic and pharmacodynamic markers
Why Choose CIRI for Biomarker Programs?
Our specialized testing capabilities, combined with robust quality management systems and experienced scientific staff, make CIRI the ideal partner for complex biomarker-driven studies. We provide validated methods, standardized platforms, and timely reporting to keep your trial on track.
